Severity: Warning
Message: file_get_contents(https://...@gmail.com&api_key=61f08fa0b96a73de8c900d749fcb997acc09&a=1): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests
Filename: helpers/my_audit_helper.php
Line Number: 197
Backtrace:
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 197
Function: file_get_contents
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 271
Function: simplexml_load_file_from_url
File: /var/www/html/application/helpers/my_audit_helper.php
Line: 3165
Function: getPubMedXML
File: /var/www/html/application/controllers/Detail.php
Line: 597
Function: pubMedSearch_Global
File: /var/www/html/application/controllers/Detail.php
Line: 511
Function: pubMedGetRelatedKeyword
File: /var/www/html/index.php
Line: 317
Function: require_once
98%
921
2 minutes
20
Objective: The performance of a gelling fiber dressing (GFD) was evaluated in adult patients undergoing split-thickness skin graft (STSG) transplantation.
Methods: A gelling fiber dressing was applied directly to the donor sites; a soft-silicone-coated foam was used as the secondary dressing. Follow-ups were scheduled for days 3 and 14, and day 21 for patients with donor sites that had not healed. The primary outcome measure was donor site progression from baseline to last visit when GFD was used. Secondary outcome measures included clinicians' and patients' evaluations of GFD performance, patients' evaluations of pain severity, dressing wear time, and adverse events.
Results: Twenty-nine of 33 participants (87.9%) had donor sites considered as "improved" at the final visit. Twenty (60.6%) donor sites were healed during the period when the GFD was used. High percentages of "good"/"very good" clinicians' ratings for the ability of GFD to absorb/retain exudate (93.3%), absorb/retain blood (96.6%), conform to the wound bed (96.8%), and maintain integrity when wet on removal (100%) were recorded. High percentages of "good"/"very good" patient ratings for comfort during wear (93.9%) and experience during dressing changes (86.6%) were also recorded. Mean pain score at GFD removal was 1.3, on a scale from 0 = no pain to 10 = worst imaginable. Median wear time per individual dressing was 14 days. Four adverse device events were reported.
Conclusions: The findings indicate the suitability of GFD for donor site management. The dressing, rated highly by clinicians and patients, was associated with good healing progression.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12345826 | PMC |
http://dx.doi.org/10.1097/ASW.0000000000000337 | DOI Listing |